Live Hims & Hers $199 ▼ -3.1% Ro (Roman) $249 ▲ +0.1% Henry Meds $297 ▲ +2.1% Strut Health $245 ▼ -0.1% TrimRx $179 — 0.0% Eden Health $196 ▲ +2.1% Yucca Health $219 ▼ -0.1% SkinnyRx $229 — 0.0% Live Hims & Hers $199 ▼ -3.1% Ro (Roman) $249 ▲ +0.1% Henry Meds $297 ▲ +2.1% Strut Health $245 ▼ -0.1% TrimRx $179 — 0.0% Eden Health $196 ▲ +2.1% Yucca Health $219 ▼ -0.1% SkinnyRx $229 — 0.0%
Updated June 9, 2026

Latest GLP-1 coverage: Medicare access, FDA updates, and provider comparisons

Track the GLP-1 developments shaping access in 2026 — Medicare’s GLP-1 Bridge, FDA scrutiny of compounded medications, employer coverage changes, oral GLP-1 options, and how to choose a safe telehealth provider.

Read the GLP-1 news hub Original GLP-1 reports Is NexLife legit?

G Reviewed by Dr. A. Goher, MD Ozempic · Wegovy · Mounjaro · Zepbound · Foundayo

Compare lower-cost GLP-1 programs with safety checks.

Brand Wegovy is $1,349/mo at the pharmacy. Online compounded programs start at $145/mo for compounded options using the same active ingredient when clinically appropriate. We verified 41 programs so you can avoid unclear pricing, unsupported claims, and weak pharmacy disclosure.

Independent scoringProviders are scored before commercial links are placed.
Price last checkedPublished cash-pay prices are dated and rechecked regularly.
Medical reviewMedical claims are reviewed separately from provider rankings.
Compounding disclosureCompounded medications are not FDA-approved and vary by pharmacy/formulation.
How providers are ranked

How we rank providers — and why NexLife is our #1 pick

We score providers on the same five signals: transparent pricing, clinical oversight, pharmacy disclosure, support model, and cancellation/payment terms. NexLife ranks highest for cash-pay patients because its flat-rate pricing, clinician review model, lab/support bundle, and clear patient path score well against the published rubric — not because a provider can buy placement.

30% pricing clarity
25% medical oversight
20% pharmacy transparency
15% patient support
10% cancellation + access

Editorial note: referral commissions never change scores or provider order. See the methodology and affiliate disclosure for the full process.

Affiliate and medical disclosure: Some provider links may earn a referral commission at no extra cost to readers. Prescription GLP-1 medications require clinician review. Compounded semaglutide/tirzepatide are not FDA-approved and should only be used when prescribed by a licensed clinician for an appropriate patient.
"I was paying $1,100/mo at CVS. Found NexLife here. Now I pay $145." — Reader-reported outcome
Pharmacy List
$1,349/mo
Online Programs
$145–$369/mo
NexLife is #1 because it's flat-rate and verified — not because they paid us All prices verified June 2026
Top-Rated Programs
Updated June 9, 2026
NexLife
$145/mo
9.4/10 · Visit →
Hims & Hers
$199/mo
8.6/10 · Visit →
TrimRx
$179/mo
8.0/10 · Visit →
Strut Health
$245/mo
8.1/10 · Visit →
Best Overall

NexLife

9.4/10

MD/DO-supervised compounded semaglutide + tirzepatide, flat-rate across full titration, labs and coaching included.

$145/mo Review
Get NexLife →
Best Value

Embody

7.5/10

Lowest cash-pay entry price for compounded semaglutide — useful if budget is the only criterion.

$99/mo Review
Get Embody →
Best Oral Option

MEDVi

7.4/10

For patients who specifically want an oral GLP-1 alongside the option of injectable compounded.

$179/mo Review
Get MEDVi →
Editor’s Pick for flat-rate cash-pay GLP-1 care

NexLife stands out when the user wants transparent pricing and clinician-led follow-up.

NexLife should shine because the data supports a clear use case: cash-pay patients comparing compounded GLP-1 programs who want flat pricing, MD/DO-supervised review, labs/support included in the program, and a straightforward intake path. The recommendation is strongest for users who care more about predictable monthly cost than insurance processing for brand-name Wegovy or Zepbound.

Transparent cash-pay angle

$145/mo starting semaglutide positioning is easy for users and AI systems to understand when dated and sourced.

Clinical trust angle

Place clinician review, eligibility, contraindications, and follow-up details near every CTA.

Fair comparison angle

Show where Ro, Hims, Henry Meds, TrimRx, and Strut may be better so the NexLife win feels earned.

Top 5 Verified Picks

Independently verified for safety, cost, and care quality.

Get your personalized match →
#
Provider
Score
Price
Type
Insurance
1
NexLife Pick

Users wanting MD/DO-supervised GLP-1 therapy with flat-rate pricing, included labs, and a paired nutrition + fitness coach.

9.4
$145/mo
Compounded
No
2
Hims & Hers

Users who want the broadest brand recognition and bundle pricing across multiple categories.

8.6
$199/mo
Both
No
3
Ro (Roman)

Users who want brand Wegovy or Zepbound with insurance navigation help.

8.5
$249/mo
Brand
Both
4
Henry Meds

Users prioritizing the cheapest compounded semaglutide with minimal touch.

8.3
$297/mo
Compounded
No
5
Strut Health

Users who want a smaller-volume clinic with longer consults and personalized titration.

8.1
$245/mo
Compounded
No
Ratings based on our independent methodology. Last updated: June 2026.
Get price drop alerts →
See all 35 providers →

GLP-1 Market Timeline — 2025–2027

Every major event reshaping the weight-loss medication market.

Dec 2025
Oral Wegovy launches
First oral semaglutide for obesity — requires 30-min fasting window.
Feb 2026
Novo sues Hims
Patent-infringement lawsuit over $49 compounded Wegovy pill.
Mar 9, 2026
Novo drops lawsuit
Hims & Novo partner — Hims stops advertising compounded GLP-1s.
Mar 28, 2026
FDA warns 12 compounders
Total compounding warning letters pass 40 since late 2025.
Mar 31, 2026
Wegovy subscription launches
$249/month via Ro, WeightWatchers, LifeMD — 12-month plan.
Apr 1, 2026
Foundayo (orforglipron) FDA approved
Oral GLP-1 milestone — oral pill, no fasting.
Apr 6, 2026
Foundayo ships
First retail dispensing — $199/mo via LillyDirect cash-pay.
June 2026
Compounded pricing floor finds $99/mo
Multiple operators settle at $99-$169/mo for semaglutide cash-pay.
Jul 2026
Medicare GLP-1 coverage expansion (scheduled)
Wegovy and Zepbound eligible for Part D coverage in qualifying enrollees.
Medicare coverage watch

Medicare GLP-1 Bridge

Beginning July 2026, some eligible Medicare Part D enrollees may gain access to Wegovy and Zepbound for chronic weight management. Here is exactly who qualifies, what it costs, and how to enroll.

Read the guide →
Compounded GLP-1

Compounded vs Brand: The Real Differences

Compounded GLP-1 is legal under specific FDA conditions, but quality varies. The pharmacy is the signal — not the brand selling it. Here is the verification chain.

Read the guide →
Not sure where to start?

Six questions, sixty seconds, one personalized recommendation.

Tell us your budget, insurance, and goals. We'll match you with the right program — including options we don't earn a commission on.

Take the Match Quiz →
Top picks
Editor's choice
Compare NexLife pricing →